2023-10-01 09213110 2024-09-30 09213110 2023-10-01 2024-09-30 09213110 2023-09-30 09213110 2022-10-01 2023-09-30 09213110 uk-core:WithinOneYear 2023-09-30 09213110 uk-core:WithinOneYear 2024-09-30 09213110 uk-core:AfterOneYear 2023-09-30 09213110 uk-core:AfterOneYear 2024-09-30 09213110 uk-core:ShareCapital 2024-09-30 09213110 uk-core:ShareCapital 2023-09-30 09213110 uk-core:RetainedEarningsAccumulatedLosses 2024-09-30 09213110 uk-core:RetainedEarningsAccumulatedLosses 2023-09-30 09213110 uk-bus:Director1 2023-10-01 2024-09-30 09213110 uk-core:CostValuation 2023-09-30 09213110 uk-core:CostValuation uk-core:Non-currentFinancialInstruments 2023-09-30 09213110 uk-core:CostValuation uk-core:Non-currentFinancialInstruments 2024-09-30 09213110 uk-core:CostValuation 2024-09-30 09213110 uk-core:Non-currentFinancialInstruments 2024-09-30 09213110 uk-core:Non-currentFinancialInstruments 2023-09-30 iso4217:GBP xbrli:pure 09213110 uk-bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 09213110 uk-bus:FRS102 2023-10-01 2024-09-30 09213110 uk-bus:FilletedAccounts 2023-10-01 2024-09-30 09213110 uk-bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30
Calscience Group Limited
Registered Number:09213110
For the year ended 30 September 2024
England and Wales
Unaudited Financial Statements
2
Registered Number :
09213110
As at 30 September 2024
Calscience Group Limited
Statement of Financial Position
£
£
2023
2024
Notes
Fixed assets
Financial assets
900,000
900,000
2
900,000
900,000
Current assets
Trade and other receivables
474,872
499,899
3
1,458
Cash and cash equivalents
2,347
502,246
476,330
Trade and other payables: amounts falling due within one year
(4,025)
(25)
4
472,305
502,221
Net current assets
Total assets less current liabilities
1,402,221
1,372,305
Trade and other payables: amounts falling due after more than
one year
(15,000)
(15,000)
5
1,387,221
Net assets
1,357,305
Capital and reserves
Called up share capital
1,411,001
1,381,001
Retained earnings
(23,780)
(23,696)
1,387,221
1,357,305
Shareholders' funds
For the year ended 30 September 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and
which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as
applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
R D Cole Director
These financial statements were approved and authorised for issue by the Board on 28 March 2025 and were signed by:
The notes form part of these financial statements
1 of 3
3
For the year ended 30 September 2024
Calscience Group Limited
Notes to the Financial Statements
Statutory Information
Calscience Group Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number
09213110.
Registered address:
40 High Street
Pershore
Worcs
WR10 1DP
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial Reporting
Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.
The financial statements have been prepared under the historical costs convention as modified by the revaluation of certain
assets.
Financial assets
Fixed asset investments are shown at cost, including consideration paid plus any deferred amounts, less any amounts written
off. Provision is made for any impairment in value.
2. Investments held as fixed assets
Shares in group and participating interests
Total
At 01 October 2023
900,000
900,000
Cost
£
£
At 30 September 2024
900,000
900,000
At 30 September 2024
Net book value
900,000
900,000
At 01 October 2023
900,000
900,000
3. Trade and other receivables
2023
2024
£
£
Amounts owed by group undertakings and participating interests
499,898
474,871
Other debtors
1
1
474,872
499,899
The debtors above include the following amounts falling due after more than one year:
Amounts owed by group undertakings and participating interests
499,898
474,871
2 of 3
4
For the year ended 30 September 2024
Calscience Group Limited
Notes to the Financial Statements Continued
4. Trade and other payables: amounts falling due within one year
2023
2024
£
£
Other creditors
25
4,025
5. Trade and other payables: amounts falling due after more than one year
2023
2024
£
£
Other creditors
15,000
15,000
6. Average number of persons employed
During the year the average number of employees was 5.
7. Transition to FRS 102
The principal accounting polices applied in the preparation of the financial statements are set out above. These policies have
been consistently applied to all the years presented, unless otherwise stated. No changes have arisen as a result of the
transition to Section 1A of Financial Reporting Standard 102.
3 of 3